Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
John Stogner & Bryan Lee Miller. (2021) Exploring the Relationships between Sexual Orientation and Gender Identity and Youth Synthetic Cannabinoid Use. Substance Use & Misuse 56:2, pages 327-332.
Read now
Read now
Vera L. Alves, João L. Gonçalves, Joselin Aguiar, Helena M. Teixeira & José S. Câmara. (2020) The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review. Critical Reviews in Toxicology 50:5, pages 359-382.
Read now
Read now
C. Cory Lowe, John M. Stogner & Bryan Lee Miller. (2020) Spice Use among Adolescents in the United States: A National Profile of Synthetic Cannabinoid Users. Journal of Child & Adolescent Substance Abuse 29:2, pages 119-128.
Read now
Read now
Alexandra Godinho, Christina Schell & John A. Cunningham. (2020) Out damn bot, out: Recruiting real people into substance use studies on the internet. Substance Abuse 41:1, pages 3-5.
Read now
Read now
Laura Orsolini, Stefania Chiappini, John M. Corkery, Amira Guirguis, Duccio Papanti & Fabrizio Schifano. (2019) The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review. Expert Review of Neurotherapeutics 19:12, pages 1253-1264.
Read now
Read now
Kirsten Elin Smith & Michele Staton. (2019) Synthetic cannabinoid use among a sample of individuals enrolled in community-based recovery programs: Are synthetic cannabinoids actually preferred to other drugs?. Substance Abuse 40:2, pages 160-169.
Read now
Read now
Faith A. Ihongbe, Timothy O. Ihongbe, Saba W. Masho & Katerina Petrov. (2018) Association between synthetic cannabinoid use and depressive symptomology: Analysis of a US national survey of high-school seniors. Journal of Substance Use 23:2, pages 113-119.
Read now
Read now
Kirsten Elin Smith, Amanda M. Bunting, Michele Staton, Robert Walker, Sara Shalash, Erin Winston & Kevin Pangburn. (2017) Examination of Synthetic Cannabinoid and Cathinone Use among a Drug-Using Offender Sample, 2013–2015. Journal of Psychoactive Drugs 49:5, pages 436-445.
Read now
Read now
Celeste M. Caviness, Bradley J. Anderson & Michael D. Stein. (2017) Energy drinks and alcohol-related risk among young adults. Substance Abuse 38:4, pages 376-381.
Read now
Read now
Jumi Hayaki, Bradley J. Anderson & Michael D. Stein. (2016) Dual cannabis and alcohol use disorders in young adults: Problems magnified. Substance Abuse 37:4, pages 579-583.
Read now
Read now
Joseph J. Palamar, Mark K. Su & Robert S. Hoffman. (2016) Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011–2014. The American Journal of Drug and Alcohol Abuse 42:1, pages 39-47.
Read now
Read now
Articles from other publishers (23)
Arianna Giorgetti, Vasco Orazietti, Francesco Paolo Busardò & Raffaele Giorgetti. (2023) Psychomotor performances relevant for driving under the combined effect of ethanol and synthetic cannabinoids: A systematic review. Frontiers in Psychiatry 14.
Crossref
Crossref
Hugo López-Pelayo, Santiago Madero, Lies Gremeaux, Sanna Rönkä & João Matias. (2022) Synthetic Cannabinoids and Cannabis: How the Patterns of Use Differ: Results from the European Web Survey on Drugs. International Journal of Mental Health and Addiction.
Crossref
Crossref
Orion Santangelo, Julie Marie Baldwin & John Stogner. (2022) Does cannabis testing in the military drive synthetic cannabinoid use? Self-reported use motivations among justice-involved veterans. International Journal of Drug Policy 106, pages 103756.
Crossref
Crossref
Liana Fattore, Matteo Marti, Rafaela Mostallino & Maria Paola Castelli. (2020) Sex and Gender Differences in the Effects of Novel Psychoactive Substances. Brain Sciences 10:9, pages 606.
Crossref
Crossref
Máté Kapitány-Fövény, Ornella Corazza, Shanna Marrinan & Zsolt Demetrovics. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions
307
325
.
. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions
295
425
.
. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions.
Annemieke Benschop, Róbert Urbán, Máté Kapitány-Fövény, Marie Claire Van Hout, Katarzyna Dąbrowska, Katalin Felvinczi, Evelyn Hearne, Susana Henriques, Zsuzsa Kaló, Gerrit Kamphausen, Joana Paula Silva, Łukasz Wieczorek, Bernd Werse, Michal Bujalski, Dirk Korf & Zsolt Demetrovics. (2020) Why do people use new psychoactive substances? Development of a new measurement tool in six European countries. Journal of Psychopharmacology 34:6, pages 600-611.
Crossref
Crossref
Koby Cohen, Shiri Rosenzweig, Paola Rosca, Albert Pinhasov, Abraham Weizman & Aviv Weinstein. (2020) Personality Traits and Psychotic Proneness Among Chronic Synthetic Cannabinoid Users. Frontiers in Psychiatry 11.
Crossref
Crossref
Mariya Prilutskaya, Oleg Yussopov, Nikolay Negay, Kuanysh Altynbekov & Makpal Tokayeva. (2020) Prevalence of new psychoactive substances addiction: a hospital-based cross-sectional study. Journal of Clinical Medicine of Kazakhstan 1:55, pages 11-16.
Crossref
Crossref
Stephanie Campos, Ellen Benoit & Eloise Dunlap. (2019) Risk management strategies of synthetic cannabis users. Drugs and Alcohol Today 19:4, pages 270-281.
Crossref
Crossref
Celeste M. Caviness, Bradley J. Anderson & Michael D. Stein. (2019) Impact of Nicotine and Other Stimulants on Sleep in Young Adults. Journal of Addiction Medicine 13:3, pages 209-214.
Crossref
Crossref
Samuel K. Cordeiro, Ryan C. Daro, Hyunuk Seung, Wendy Klein-Schwartz & Hong K. Kim. (2018) Evolution of clinical characteristics and outcomes of synthetic cannabinoid receptor agonist exposure in the United States: analysis of National Poison Data System data from 2010 to 2015. Addiction 113:10, pages 1850-1861.
Crossref
Crossref
Huiqiong Deng, Christopher D. Verrico, Thomas R. Kosten & David A. Nielsen. (2018) Psychosis and synthetic cannabinoids. Psychiatry Research 268, pages 400-412.
Crossref
Crossref
Jumi Hayaki, Bradley J. Anderson & Michael D. Stein. (2018) Dual use of alcohol and marijuana and condomless sex in young adult men and women: A within-subject day-level analysis. The American Journal on Addictions 27:5, pages 413-418.
Crossref
Crossref
Ryan Graddy, Megan E. Buresh & Darius A. Rastegar. (2018) New and Emerging Illicit Psychoactive Substances. Medical Clinics of North America 102:4, pages 697-714.
Crossref
Crossref
Michael D. Stein, Celeste M. Caviness, Emily F. Morse, Kristin R. Grimone, Daniel Audet, Debra S. Herman, Ethan Moitra & Bradley J. Anderson. (2018) A developmental-based motivational intervention to reduce alcohol and marijuana use among non-treatment-seeking young adults: a randomized controlled trial. Addiction 113:3, pages 440-453.
Crossref
Crossref
Huiqiong Deng, Satyajit Mohite, Robert Suchting, David A. Nielsen & Olaoluwa O. Okusaga. (2018) Impact of synthetic cannabinoid use on hospital stay in patients with bipolar disorder versus schizophrenia, or other psychotic disorders. Psychiatry Research 261, pages 248-252.
Crossref
Crossref
Spencer D. Li, Xiaohua Zhang, Wei Tang & Yiwei Xia. (2017) Predictors and Implications of Synthetic Drug Use Among Adolescents in the Gambling Capital of China. SAGE Open 7:4, pages 215824401773303.
Crossref
Crossref
Aviv M. Weinstein, Paola Rosca, Liana Fattore & Edythe D. London. (2017) Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health. Frontiers in Psychiatry 8.
Crossref
Crossref
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott & Jim McCambridge. (2017) The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations. Public Health Research 5:4, pages 1-138.
Crossref
Crossref
Francois R. Lamy, Raminta Daniulaityte, Ramzi W. Nahhas, Monica J. Barratt, Alan G. Smith, Amit Sheth, Silvia S. Martins, Edward W. Boyer & Robert G. Carlson. (2017) Increases in synthetic cannabinoids-related harms: Results from a longitudinal web-based content analysis. International Journal of Drug Policy 44, pages 121-129.
Crossref
Crossref
Katherine M. Keyes, Caroline Rutherford, Ava Hamilton & Joseph J. Palamar. (2016) Age, period, and cohort effects in synthetic cannabinoid use among US adolescents, 2011–2015. Drug and Alcohol Dependence 166, pages 159-167.
Crossref
Crossref